Ekso Bionics Holdings, Inc. Common Stock earnings per share and revenue
On Oct 28, 2025, EKSO reported earnings of -0.54 USD per share (EPS) for Q3 25, beating the estimate of -1.16 USD, resulting in a 53.76% surprise. Revenue reached 4.23 million, compared to an expected 4.43 million, with a -4.65% difference. The market reacted with a +9.15% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were Ekso Bionics Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ekso Bionics Holdings, Inc. Common Stock reported EPS of -$0.54, beating estimates by 53.76%, and revenue of $4.23M, -4.65% below expectations.
How did the market react to Ekso Bionics Holdings, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 9.15%, changed from $4.81 before the earnings release to $5.25 the day after.
When is Ekso Bionics Holdings, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Ekso Bionics Holdings, Inc. Common Stock's next earnings report?
Based on --
analysts, Ekso Bionics Holdings, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.